Lilly Bamlanivimab Antibody Playbook
This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.
Related Content
Drug Shortages Continue to Impact Children’s Hospitals
Supply chain disruptions strain children’s hospital budgets, staffing, and patient care.
How Drug Shortages Disrupt Pediatric Care
Drug shortages strain children’s hospital budgets, staffing, and patient care. Learn what’s driving it and what’s being done to fix it.
Boosting Free Vaccination Access in Rural Counties
Arkansas Children’s helps pharmacies and schools become Vaccines for Children providers.